These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 12768367

  • 1. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation.
    Sugo H, Balderson GA, Crawford DH, Fawcett J, Lynch SV, Strong RW, Futagawa S.
    Surg Today; 2003; 33(6):421-5. PubMed ID: 12768367
    [Abstract] [Full Text] [Related]

  • 2. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M, Berenguer M, Rayón JM, Córdoba J, Argüello L, Carrasco D, García-Herola A, Olaso V, De Juan M, Gobernado M, Mir J, Berenguer J.
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [Abstract] [Full Text] [Related]

  • 3. Histological and clinical outcome after liver transplantation for hepatitis C.
    Shuhart MC, Bronner MP, Gretch DR, Thomassen LV, Wartelle CF, Tateyama H, Emerson SS, Perkins JD, Carithers RL.
    Hepatology; 1997 Dec; 26(6):1646-52. PubMed ID: 9398011
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis C virus recurrence after liver transplantation: relationship to anti-HCV core IgM, genotype, and level of viremia.
    Crespo J, Carte B, Lozano JL, Casafont F, Rivero M, de la Cruz F, Pons-Romero F.
    Am J Gastroenterol; 1997 Sep; 92(9):1458-62. PubMed ID: 9317062
    [Abstract] [Full Text] [Related]

  • 5. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
    Arnold JC, Töx U, Goeser T, Otto G, Müller HM, Hofmann WJ, Stremmel W, Theilmann L.
    Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
    [Abstract] [Full Text] [Related]

  • 6. Long-term outcome of hepatitis C virus infection after liver transplantation.
    Böker KH, Dalley G, Bahr MJ, Maschek H, Tillmann HL, Trautwein C, Oldhaver K, Bode U, Pichlmayr R, Manns MP.
    Hepatology; 1997 Jan; 25(1):203-10. PubMed ID: 8985291
    [Abstract] [Full Text] [Related]

  • 7. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients.
    Testa G, Crippin JS, Netto GJ, Goldstein RM, Jennings LW, Brkic BS, Brooks BK, Levy MF, Gonwa TA, Klintmalm GB.
    Liver Transpl; 2000 Sep; 6(5):553-61. PubMed ID: 10980053
    [Abstract] [Full Text] [Related]

  • 8. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
    Negro F, Giostra E, Rubbia-Brandt L, Mentha G, Colucci G, Morel P, Quadri R, Perrin L, Hadengue A.
    J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
    [Abstract] [Full Text] [Related]

  • 9. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P.
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [Abstract] [Full Text] [Related]

  • 10. Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation.
    D'Errico-Grigioni A, Fiorentino M, Vasuri F, Gruppioni E, Fabbrizio B, Zucchini N, Ballardini G, Morelli C, Pinna AD, Grigioni WF.
    Liver Transpl; 2008 Mar; 14(3):313-20. PubMed ID: 18306349
    [Abstract] [Full Text] [Related]

  • 11. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J, Ciria R, Pleguezuelo M, de la Mata M, Muntané J, Naranjo A, Sánchez-Hidalgo J, Marchal T, Rufián S, López-Cillero P.
    Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
    [Abstract] [Full Text] [Related]

  • 12. Long-term outcome of hepatitis C infection after liver transplantation.
    Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, Williams R.
    N Engl J Med; 1996 Mar 28; 334(13):815-20. PubMed ID: 8596547
    [Abstract] [Full Text] [Related]

  • 13. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection.
    Schirren CA, Jung M, Worzfeld T, Mamin M, Baretton GB, Gruener NH, Gerlach JT, Diepolder HM, Zachoval R, Pape GR.
    Liver Transpl; 2000 Mar 28; 6(2):222-8. PubMed ID: 10719024
    [Abstract] [Full Text] [Related]

  • 14. Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation.
    Chopra KB, Demetris AJ, Blakolmer K, Dvorchik I, Laskus T, Wang LF, Araya VR, Dodson F, Fung JJ, Rakela J, Vargas HE.
    Transplantation; 2003 Nov 27; 76(10):1487-91. PubMed ID: 14657691
    [Abstract] [Full Text] [Related]

  • 15. Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution.
    Zekry A, Whiting P, Crawford DH, Angus PW, Jeffrey GP, Padbury RT, Gane EJ, McCaughan GW, Australian and New Zealand Liver Transplant Clinical Study Group.
    Liver Transpl; 2003 Apr 27; 9(4):339-47. PubMed ID: 12682883
    [Abstract] [Full Text] [Related]

  • 16. Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis.
    Radecke K, Frühauf NR, Miller M, Ross B, Köditz R, Malagó M, Broelsch CE, Gerken G, Treichel U.
    Liver Int; 2005 Feb 27; 25(1):101-8. PubMed ID: 15698406
    [Abstract] [Full Text] [Related]

  • 17. Long-term follow-up of hepatitis C virus (HCV) infection in liver transplant patients.
    Villa E, Grottola A, Buttafoco P, Merighi A, Ferretti I, Trande P, Zoboli P, Camellini L, Callea F, De Palma M.
    Clin Transplant; 1995 Jun 27; 9(3 Pt 1):160-4. PubMed ID: 7549054
    [Abstract] [Full Text] [Related]

  • 18. Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis.
    Benvegnù L, Pontisso P, Cavalletto D, Noventa F, Chemello L, Alberti A.
    Hepatology; 1997 Jan 27; 25(1):211-5. PubMed ID: 8985292
    [Abstract] [Full Text] [Related]

  • 19. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
    Yosry A, Esmat G, El-Serafy M, Omar A, Doss W, Said M, Abdel-Bary A, Hosny A, Marawan I, El-Malt O, Kamel RR, Hatata Y, Ghali A, Sabri H, Kamel S, El-Gbaly H, Tanaka K.
    Transplant Proc; 2008 Jun 27; 40(5):1481-4. PubMed ID: 18589133
    [Abstract] [Full Text] [Related]

  • 20. Risk factors in patients with rapid recurrent hepatitis C virus-related cirrhosis within 1 year after liver transplantation.
    Zimmermann T, Otto C, Hoppe-Lotichius M, Biesterfeld S, Lautem A, Knaak M, Zimmermann A, Barreiros AP, Heise M, Schattenberg JM, Sprinzl MF, Galle PR, Otto G, Schuchmann M.
    Transplant Proc; 2009 Jun 27; 41(6):2549-56. PubMed ID: 19715972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.